Villadarez, Rachel .

HRN: 27-57-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2025
CEFUROXIME 500MG (TAB)
09/23/2025
09/30/2025
PO
1 Tab
BID
S/P NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines